日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists Versus Other Glucose-Lowering Agents in People With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Data

胰高血糖素样肽-1受体激动剂与其他降糖药物治疗2型糖尿病患者的肾脏结局：一项基于真实世界数据的系统评价和荟萃分析

期刊:Diabetes-Metabolism Research and Reviews
影响因子:6
doi:10.1002/dmrr.70066
Fishkin, Alisa; Rozenberg, Aliza; Schechter, Meir; Sehtman-Shachar, Dvora R; Aharon-Hananel, Genya; Leibowitz, Gil; Yanuv, Ilan; Mosenzon, Ofri
糖尿病
信号转导
代谢
发表日期：2025
文献求助 收藏

Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence

GLP-1受体激动剂与基础胰岛素治疗2型糖尿病患者肾功能丧失和蛋白尿进展的比较：真实世界证据

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-023-01829-0
Schechter, Meir; Melzer Cohen, Cheli; Fishkin, Alisa; Rozenberg, Aliza; Yanuv, Ilan; Sehtman-Shachar, Dvora R; Chodick, Gabriel; Clark, Alice; Abrahamsen, Trine J; Lawson, Jack; Karasik, Avraham; Mosenzon, Ofri
GLP-1
信号转导
代谢
糖尿病
免疫/内分泌
发表日期：2023
文献求助 收藏

Long-Term, Real-World Kidney Outcomes with SGLT2i versus DPP4i in Type 2 Diabetes without Cardiovascular or Kidney Disease

在无心血管或肾脏疾病的2型糖尿病患者中，SGLT2抑制剂与DPP4抑制剂的长期真实世界肾脏结局比较

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.0000000000000218
Melzer Cohen, Cheli; Schechter, Meir; Rozenberg, Aliza; Yanuv, Ilan; Sehtman-Shachar, Dvora R; Fishkin, Alisa; Rosenzweig, Doron; Chodick, Gabriel; Karasik, Avraham; Mosenzon, Ofri
SGLT2
糖尿病
DPP4
代谢
发表日期：2023
文献求助 收藏

Medical cannabis for pain management in patients undergoing chronic hemodialysis: randomized, double-blind, cross-over, feasibility study

医用大麻用于慢性血液透析患者疼痛管理：一项随机、双盲、交叉可行性研究

期刊:Clinical Kidney Journal
影响因子:4.6
doi:10.1093/ckj/sfac275
Kliuk-Ben Bassat, Orit; Schechter, Meir; Ashtamker, Natalia; Yanuv, Ilan; Rozenberg, Aliza; Hirshberg, Boaz; Grupper, Ayelet; Vaisman, Nachum; Brill, Silviu; Mosenzon, Ofri
发表日期：2023
文献求助 收藏

Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults

糖尿病-心肾谱系流行病学：一项纳入140万成年人的横断面研究

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-022-01521-9
Schechter, Meir; Melzer Cohen, Cheli; Yanuv, Ilan; Rozenberg, Aliza; Chodick, Gabriel; Bodegård, Johan; Leiter, Lawrence A; Verma, Subodh; Lambers Heerspink, Hiddo J; Karasik, Avraham; Mosenzon, Ofri
糖尿病
代谢
发表日期：2022
文献求助 收藏

Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial

达格列净预防2型糖尿病患者肾脏疾病：DECLARE-TIMI 58试验的事后分析

期刊:
影响因子:
doi:10.2337/dc22-0382
Mosenzon, Ofri; Raz, Itamar; Wiviott, Stephen D; Schechter, Meir; Goodrich, Erica L; Yanuv, Ilan; Rozenberg, Aliza; Murphy, Sabina A; Zelniker, Thomas A; Langkilde, Anna Maria; Gause-Nilsson, Ingrid A M; Fredriksson, Martin; Johansson, Peter A; Wilding, John P H; McGuire, Darren K; Bhatt, Deepak L; Leiter, Lawrence A; Cahn, Avivit; Dwyer, Jamie P; Heerspink, Hiddo J L; Sabatine, Marc S
糖尿病
TIM
代谢
发表日期：2022
文献求助 收藏

Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence

钠/葡萄糖协同转运蛋白2抑制剂在2型糖尿病低肾风险患者中的心肾结局：真实世界证据

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-021-01362-y
Schechter, Meir; Melzer-Cohen, Cheli; Rozenberg, Aliza; Yanuv, Ilan; Chodick, Gabriel; Karasik, Avraham; Kosiborod, Mikhail; Mosenzon, Ofri
糖尿病
代谢
发表日期：2021
文献求助 收藏

The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

达格列净对 DECLARE-TIMI 58 研究中蛋白尿的影响

期刊:
影响因子:
doi:10.2337/dc21-0076
Mosenzon, Ofri; Wiviott, Stephen D; Heerspink, Hiddo J L; Dwyer, Jamie P; Cahn, Avivit; Goodrich, Erica L; Rozenberg, Aliza; Schechter, Meir; Yanuv, Ilan; Murphy, Sabina A; Zelniker, Thomas A; Gause-Nilsson, Ingrid A M; Langkilde, Anna Maria; Fredriksson, Martin; Johansson, Peter A; Bhatt, Deepak L; Leiter, Lawrence A; McGuire, Darren K; Wilding, John P H; Sabatine, Marc S; Raz, Itamar
TIM
发表日期：2021
文献求助 收藏